North America Pharma ADMET Testing Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Pharma ADMET Testing Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Pharma ADMET Testing Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Pharma ADMET Testing Market Regional Analysis

6.2 North America Pharma ADMET Testing Market Revenue 2020-2028 (US$ Million)

6.3 North America Pharma ADMET Testing Market Forecast Analysis

7. North America Pharma ADMET Testing Market Analysis – by Testing Type

7.1 In Vivo ADMET Testing

7.1.1 Overview
7.1.2 In Vivo ADMET Testing: North America Pharma ADMET Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.2 In Vitro ADMET Testing

7.2.1 Overview
7.2.2 In Vitro ADMET Testing: North America Pharma ADMET Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.3 In Silico ADMET Testing

7.3.1 Overview
7.3.2 In Silico ADMET Testing: North America Pharma ADMET Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. North America Pharma ADMET Testing Market Analysis – by Technology

8.1 Cell Culture

8.1.1 Overview
8.1.2 Cell Culture: North America Pharma ADMET Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.2 High Throughput

8.2.1 Overview
8.2.2 High Throughput: North America Pharma ADMET Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.3 Molecular Imaging

8.3.1 Overview
8.3.2 Molecular Imaging: North America Pharma ADMET Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.4 OMICS Technology

8.4.1 Overview
8.4.2 OMICS Technology: North America Pharma ADMET Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. North America Pharma ADMET Testing Market Analysis – by Application

9.1 Systemic Toxicity

9.1.1 Overview
9.1.2 Systemic Toxicity: North America Pharma ADMET Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.2 Renal Toxicity

9.2.1 Overview
9.2.2 Renal Toxicity: North America Pharma ADMET Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.3 Hepatotoxicity

9.3.1 Overview
9.3.2 Hepatotoxicity: North America Pharma ADMET Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.4 Neurotoxicity

9.4.1 Overview
9.4.2 Neurotoxicity: North America Pharma ADMET Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. North America Pharma ADMET Testing Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Pharma ADMET Testing Market Breakdown, by Key Country, 2023 and 2028 (%)
10.2.1.1 North America Pharma ADMET Testing Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 US: North America Pharma ADMET Testing Market Breakdown, by Testing Type
10.2.1.1.2 US: North America Pharma ADMET Testing Market Breakdown, by Technology
10.2.1.1.3 US: North America Pharma ADMET Testing Market Breakdown, by Application

10.2.1.2 Canada: North America Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Canada: North America Pharma ADMET Testing Market Breakdown, by Testing Type
10.2.1.2.2 Canada: North America Pharma ADMET Testing Market Breakdown, by Technology
10.2.1.2.3 Canada: North America Pharma ADMET Testing Market Breakdown, by Application

10.2.1.3 Mexico : North America Pharma ADMET Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 Mexico : North America Pharma ADMET Testing Market Breakdown, by Testing Type
10.2.1.3.2 Mexico : North America Pharma ADMET Testing Market Breakdown, by Technology
10.2.1.3.3 Mexico : North America Pharma ADMET Testing Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Agilent Technologies, Inc.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Bio-Rad Laboratories, Inc.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Biovia (Dassault Systèmes)

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Charles River Laboratories

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 CMIC HOLDINGS Co., LTD

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Cyprotex Limited

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 IQVIA Inc.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 MERCK KGaA

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Promega Corporation

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Wuxi AppTec

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Pharma ADMET Testing Market

Analysis By Testing Type (In Vivo ADMET Testing, In Vitro ADMET Testing, and In Silico ADMET Testing), Technology (Cell Culture, High Throughput, Molecular Imaging, and OMICS Technology), and Application (Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, and Others)